These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 33350984)

  • 1. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90.
    Xu G; Fu S; Zhan X; Wang Z; Zhang P; Shi W; Qin N; Chen Y; Wang C; Niu M; Guo Y; Wang J; Bai Z; Xiao X
    JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33350984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases.
    Shi W; Xu G; Zhan X; Gao Y; Wang Z; Fu S; Qin N; Hou X; Ai Y; Wang C; He T; Liu H; Chen Y; Liu Y; Wang J; Niu M; Guo Y; Xiao X; Bai Z
    Cell Death Dis; 2020 Apr; 11(4):252. PubMed ID: 32312957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homotherapy for heteropathy: therapeutic effect of Butein in NLRP3-driven diseases.
    Liao W; Li Y; Liu J; Mou Y; Zhao M; Liu J; Zhang T; Sun Q; Tang J; Wang Z
    Cell Commun Signal; 2024 Jun; 22(1):315. PubMed ID: 38849890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-(2-Oxo-2-phenylethylidene)-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-one (compound 1), a novel potent Nrf2/ARE inducer, protects against DSS-induced colitis via inhibiting NLRP3 inflammasome.
    Wang Y; Wang H; Qian C; Tang J; Zhou W; Liu X; You Q; Hu R
    Biochem Pharmacol; 2016 Feb; 101():71-86. PubMed ID: 26588861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-κB pathway.
    Liu Q; Zuo R; Wang K; Nong FF; Fu YJ; Huang SW; Pan ZF; Zhang Y; Luo X; Deng XL; Zhang XX; Zhou L; Chen Y
    Acta Pharmacol Sin; 2020 Jun; 41(6):771-781. PubMed ID: 31937929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage.
    Huang S; Wu Y; Zhao Z; Wu B; Sun K; Wang H; Qin L; Bai F; Leng Y; Tang W
    Metabolism; 2021 Jul; 120():154797. PubMed ID: 33984334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of chalcone analogues as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activities.
    Zhang C; Yue H; Sun P; Hua L; Liang S; Ou Y; Wu D; Wu X; Chen H; Hao Y; Hu W; Yang Z
    Eur J Med Chem; 2021 Jul; 219():113417. PubMed ID: 33845232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
    Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
    J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glaucocalyxin A alleviates LPS-mediated septic shock and inflammation via inhibiting NLRP3 inflammasome activation.
    Hou X; Xu G; Wang Z; Zhan X; Li H; Li R; Shi W; Wang C; Chen Y; Ai Y; Xiao X; Bai Z
    Int Immunopharmacol; 2020 Apr; 81():106271. PubMed ID: 32062071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases.
    Liu H; Zhan X; Xu G; Wang Z; Li R; Wang Y; Qin Q; Shi W; Hou X; Yang R; Wang J; Xiao X; Bai Z
    Pharmacol Res; 2021 Feb; 164():105384. PubMed ID: 33352229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydrocostus lactone inhibits NLRP3 inflammasome activation by blocking ASC oligomerization and prevents LPS-mediated inflammation in vivo.
    Chen Y; Li R; Wang Z; Hou X; Wang C; Ai Y; Shi W; Zhan X; Wang JB; Xiao X; Bai Z; Sun H; Xu G
    Cell Immunol; 2020 Mar; 349():104046. PubMed ID: 32057354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen sulfide protects against DSS-induced colitis by inhibiting NLRP3 inflammasome.
    Qin M; Long F; Wu W; Yang D; Huang M; Xiao C; Chen X; Liu X; Zhu YZ
    Free Radic Biol Med; 2019 Jun; 137():99-109. PubMed ID: 31026586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells.
    Chen HW; Yen CC; Kuo LL; Lo CW; Huang CS; Chen CC; Lii CK
    Toxicol Appl Pharmacol; 2020 Apr; 393():114941. PubMed ID: 32126212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7-NLRP3 interaction.
    Li Q; Feng H; Wang H; Wang Y; Mou W; Xu G; Zhang P; Li R; Shi W; Wang Z; Fang Z; Ren L; Wang Y; Lin L; Hou X; Dai W; Li Z; Wei Z; Liu T; Wang J; Guo Y; Li P; Zhao X; Zhan X; Xiao X; Bai Z
    EMBO Rep; 2022 Feb; 23(2):e53499. PubMed ID: 34882936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoid VI-16 protects against DSS-induced colitis by inhibiting Txnip-dependent NLRP3 inflammasome activation in macrophages via reducing oxidative stress.
    Zhao Y; Guo Q; Zhu Q; Tan R; Bai D; Bu X; Lin B; Zhao K; Pan C; Chen H; Lu N
    Mucosal Immunol; 2019 Sep; 12(5):1150-1163. PubMed ID: 31152156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HSP90 and Activation of HSF1 Diminish Macrophage NLRP3 Inflammasome Activity in Alcohol-Associated Liver Injury.
    Choudhury A; Bullock D; Lim A; Argemi J; Orning P; Lien E; Bataller R; Mandrekar P
    Alcohol Clin Exp Res; 2020 Jun; 44(6):1300-1311. PubMed ID: 32282939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tanshinone I specifically suppresses NLRP3 inflammasome activation by disrupting the association of NLRP3 and ASC.
    Zhao J; Liu H; Hong Z; Luo W; Mu W; Hou X; Xu G; Fang Z; Ren L; Liu T; Wen J; Shi W; Wei Z; Yang Y; Zou W; Zhao J; Xiao X; Bai Z; Zhan X
    Mol Med; 2023 Jul; 29(1):84. PubMed ID: 37400760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin alleviates DSS-induced colitis via inhibiting NLRP3 inflammsome activation and IL-1β production.
    Gong Z; Zhao S; Zhou J; Yan J; Wang L; Du X; Li H; Chen Y; Cai W; Wu J
    Mol Immunol; 2018 Dec; 104():11-19. PubMed ID: 30396035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAP-1 ameliorates DSS-induced colitis with involvement of NLRP3 inflammasome pathway.
    Mei Y; Fang C; Ding S; Liu X; Hu J; Xu J; Mei Q
    Int Immunopharmacol; 2019 Oct; 75():105776. PubMed ID: 31351364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse Colitis.
    Dai Z; Chen XY; An LY; Li CC; Zhao N; Yang F; You ST; Hou CZ; Li K; Jiang C; You QD; Di B; Xu LL
    J Med Chem; 2021 Jan; 64(1):871-889. PubMed ID: 33332136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.